Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated:  6/16/2016
Clinical Research Facility
mi
from
Bedford, TX
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated: 6/16/2016
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated:  6/16/2016
Clinical Research Facility
mi
from
Tyler, TX
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated: 6/16/2016
Clinical Research Facility
mi
from
Tyler, TX
Click here to add this to my saved trials
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated:  6/16/2016
Clinical Research Facility
mi
from
Fairfax, VA
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated: 6/16/2016
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated:  6/16/2016
mi
from
Buenos Aires,
Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer
A Randomized, Open Label Phase 3 Study of MM-398, With or Without 5-Fluorouracil and Leucovorin, Versus 5 Fluorouracil and Leucovorin in Patients With Metastatic Pancreatic Cancer Who Have Failed Prior Gemcitabine-based Therapy
Status: Enrolling
Updated: 6/16/2016
mi
from
Buenos Aires,
Click here to add this to my saved trials
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated:  6/16/2016
San Luis Valley Regional Medical Center
mi
from
Alamosa, CO
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated: 6/16/2016
San Luis Valley Regional Medical Center
mi
from
Alamosa, CO
Click here to add this to my saved trials
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated:  6/16/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated: 6/16/2016
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated:  6/16/2016
Denver Health and Hospital Authority
mi
from
Denver, CO
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated: 6/16/2016
Denver Health and Hospital Authority
mi
from
Denver, CO
Click here to add this to my saved trials
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated:  6/16/2016
Shaw Cancer Center
mi
from
Eagle, CO
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated: 6/16/2016
Shaw Cancer Center
mi
from
Eagle, CO
Click here to add this to my saved trials
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated:  6/16/2016
Valley View Medical Center
mi
from
Glenwood Springs, CO
Apoyo Con Carino: Patient Navigation for Palliative Care
Apoyo Con Carino: Patient Navigation to Improve Palliative Care Outcomes for Latinos With Advanced Cancer
Status: Enrolling
Updated: 6/16/2016
Valley View Medical Center
mi
from
Glenwood Springs, CO
Click here to add this to my saved trials
PET Imaging of Intracranial Cancers With 18F-FSPG
An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers
Status: Enrolling
Updated:  6/16/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
PET Imaging of Intracranial Cancers With 18F-FSPG
An Open-Label Study of the Efficacy of 18F-FSPG PET/CT in Subjects With Intracranial Cancers
Status: Enrolling
Updated: 6/16/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery
A Pilot Evaluation of the Efficacy of HistoScanning™ in Predicting the Presence and Location of Prostate Cancer in Men Undergoing Radical Prostatectomy
Status: Enrolling
Updated:  6/16/2016
Smilow Comprehensive Prostate Cancer Center
mi
from
New York, NY
Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery
A Pilot Evaluation of the Efficacy of HistoScanning™ in Predicting the Presence and Location of Prostate Cancer in Men Undergoing Radical Prostatectomy
Status: Enrolling
Updated: 6/16/2016
Smilow Comprehensive Prostate Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
Phase I Study of Sunitinib With FOLFIRI (Irinotecan, 5-Fluorouracil and Leucovorin) for Advanced Gastroesophageal Cancers
Status: Enrolling
Updated:  6/20/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer
Phase I Study of Sunitinib With FOLFIRI (Irinotecan, 5-Fluorouracil and Leucovorin) for Advanced Gastroesophageal Cancers
Status: Enrolling
Updated: 6/20/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated:  6/20/2016
University of California at Los Angeles Div. of Hematology/Oncology
mi
from
Los Angeles, CA
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated: 6/20/2016
University of California at Los Angeles Div. of Hematology/Oncology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated:  6/20/2016
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8)
mi
from
Houston, TX
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated: 6/20/2016
University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8)
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated:  6/20/2016
Novartis Investigative Site
mi
from
Leuven,
A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients
A Phase Ib, Open-label, Multi-center, Dose-escalation Study of Oral BKM120 in Combination With Oral GSK1120212 in Adult Patients With Selected Advanced Solid Tumors.
Status: Enrolling
Updated: 6/20/2016
Novartis Investigative Site
mi
from
Leuven,
Click here to add this to my saved trials
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated:  6/20/2016
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated: 6/20/2016
Columbia University Herbert Irving Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated:  6/20/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated: 6/20/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated:  6/20/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated: 6/20/2016
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated:  6/20/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Status: Enrolling
Updated: 6/20/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Alaska Urology Institute Alaska Clinical Research Center
mi
from
Anchorage, AK
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Alaska Urology Institute Alaska Clinical Research Center
mi
from
Anchorage, AK
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
University of Colorado, Denver Medical Campus
mi
from
Aurora, CO
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
University of Colorado, Denver Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Urology Center of Colorado
mi
from
Denver, CO
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Urology Center of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Urological Research Network
mi
from
Hialeah, FL
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Urological Research Network
mi
from
Hialeah, FL
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Lakeland Regional Health Systems
mi
from
Lakeland, FL
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Lakeland Regional Health Systems
mi
from
Lakeland, FL
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Spectrum Health Medical Group
mi
from
Grand Rapids, MI
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Spectrum Health Medical Group
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Delaware Valley Urology, LLC
mi
from
Voorhees, NJ
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Delaware Valley Urology, LLC
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Carolina Urology Partners
mi
from
Gastonia, NC
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Carolina Urology Partners
mi
from
Gastonia, NC
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Lancaster Urology
mi
from
Lancaster, PA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Lancaster Urology
mi
from
Lancaster, PA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Huntsman Cancer Hospital
mi
from
Salt Lake City, UT
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Huntsman Cancer Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Virginia Urology
mi
from
Richmond, VA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Virginia Urology
mi
from
Richmond, VA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Univ of Washington
mi
from
Seattle, WA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated:  6/20/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Status: Enrolling
Updated: 6/20/2016
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluating Cancer Survivorship Care Models
Evaluating Cancer Survivorship Care Models
Status: Enrolling
Updated:  6/20/2016
George Washington University
mi
from
Washington,
Evaluating Cancer Survivorship Care Models
Evaluating Cancer Survivorship Care Models
Status: Enrolling
Updated: 6/20/2016
George Washington University
mi
from
Washington,
Click here to add this to my saved trials
Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy
A Phase 1 Study of Reovirus Serotype 3 - Dearing Strain (REOLYSIN®) (NSC 729968) in Patients With Ovarian, Primary Peritoneal and Fallopian Tube Carcinoma
Status: Enrolling
Updated:  6/21/2016
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy
A Phase 1 Study of Reovirus Serotype 3 - Dearing Strain (REOLYSIN®) (NSC 729968) in Patients With Ovarian, Primary Peritoneal and Fallopian Tube Carcinoma
Status: Enrolling
Updated: 6/21/2016
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Birmingham, AL
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Santa Maria, CA
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Santa Maria, CA
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Vallejo, CA
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Vallejo, CA
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Denver, CO
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Tucker, GA
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Tucker, GA
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Maywood, IL
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Sioux City, IA
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Sioux City, IA
Click here to add this to my saved trials
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated:  6/21/2016
Clinical Research Facility
mi
from
Boston, MA
Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
International, Multi-Center, Open-label, Treatment Extension Study of Iniparib as Monotherapy or in Combination Chemotherapeutic Regimens in Cancer Patients Who Have Derived Clinical Benefit From Iniparib Following Completion of a Phase 1, 2 or 3 Parental Study
Status: Enrolling
Updated: 6/21/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials